D-Queued said:
How much EPO do you think he was doing in 1999 in the middle of the Tour?
Dave.
Ashenden in 2009
And as far as the fluctuations you speak of, when we took the samples' dates, and matched them with the percentage of isoforms, and overlaid that with the performances during the Tour de France, then a clear pattern begins to emerge. You can see that on some days there's a preponderance of EPO in the urine sample, perhaps on the next day they come down a little bit, then they come back up, which is suggesting you've taken another EPO injection.
You don't have EPO every single day. You might take it every two or three days. So your values go up or down according to when you took those injections and when those urine samples were taken. Now, you overlay all of those data together and you can begin to see a pattern that's consistent with EPO use.
Stage
Vial #
Visual
Interpretation
% Isoforms
Stage
description
Prologue
160297
+
100
1
157372
+
89.7
2-7
Out of lead,
not tested
8
186584
+
To be reanalyzed
Metz ITT
Rest day
9
185557
+
96.6
Sestriere
10
185479
+
88.7
L'Alpe d'Huez
11
185476
Sample missing
12
185475
+
95.2
13
185895
+
Weak intensity, no % recorded
14
186397
+
89.4
Rest day
15-20
Undetectable, insufficient EPO in urine
Sorry, not very readable.
I suggest you go to the original ashenden 2009 interview
http://nyvelocity.com/content/interviews/2009/michael-ashenden